CTKB vs TXG
Cytek Biosciences, Inc. - Common Stock · 10x Genomics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | CTKB | TXG |
|---|---|---|
| Price | $6.14 | $83.62 |
| Market Cap | $798.10M | $10.68B |
| P/E | — | — |
| P/B | 2.48 | 12.93 |
| P/S | 3.96 | 16.61 |
| ROE | -20.7% | -5.3% |
| Net Margin | -33.0% | -6.8% |
| Gross Margin | 51.8% | 69.1% |
| Revenue Growth | 0.5% | 5.2% |
| Dividend Yield | — | — |
| EPS | -$0.51 | -$0.34 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.